These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 24532678)

  • 1. Fluorescence optical imaging as a novel technique for the visualisation of inflammation in patients with systemic sclerosis with Raynaud's phenomenon: a pilot study.
    Pfeil A; Drummer KF; Oelzner P; Böttcher J; Jung C; Wolf G
    Ann Rheum Dis; 2014 Jun; 73(6):1279-80. PubMed ID: 24532678
    [No Abstract]   [Full Text] [Related]  

  • 2. Sex and time to diagnosis in systemic sclerosis: an updated analysis of 1,129 patients from the Canadian scleroderma research group registry.
    Delisle VC; Hudson M; Baron M; Thombs BD; And The Canadian Scleroderma Research Group A
    Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-10-4. PubMed ID: 24144459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time to diagnosis in systemic sclerosis: is sex a factor?
    Hudson M; Thombs B; Baron M;
    Arthritis Rheum; 2009 Feb; 61(2):274-8. PubMed ID: 19177534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [An elderly woman with stiffness of the thumb].
    Franssen LE; Franssen MJ; Jeurissen M
    Ned Tijdschr Geneeskd; 2012; 156(47):A4550. PubMed ID: 23171559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic Sclerosis Sine Scleroderma.
    Manoria P; Joshi P; Sharma P; Jha RK
    J Assoc Physicians India; 2014 Dec; 62(12):54-6. PubMed ID: 26259425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Application of Fluorescence Optical Imaging in Systemic Sclerosis.
    Pfeil A; Drummer KF; Böttcher J; Jung C; Oelzner P; Renz DM; Franz M; Hansch A; Wolf G
    Biomed Res Int; 2015; 2015():658710. PubMed ID: 26357658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pilot study to determine whether transient receptor potential melastatin type 8 (TRPM8) antibodies are detected in scleroderma.
    Shah AA; Montagne J; Oh SY; Wigley FM; Casciola-Rosen L
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S123-6. PubMed ID: 26242276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Esophageal motility in Raynaud's disease, systemic scleroderma and presclerodermal Raynaud's syndrome].
    Hostein J; Bost R; Carpentier P; Franco A; Fournet J
    Gastroenterol Clin Biol; 1985 Feb; 9(2):130-5. PubMed ID: 3979734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modified-release sildenafil reduces Raynaud's phenomenon attack frequency in limited cutaneous systemic sclerosis.
    Herrick AL; van den Hoogen F; Gabrielli A; Tamimi N; Reid C; O'Connell D; Vázquez-Abad MD; Denton CP
    Arthritis Rheum; 2011 Mar; 63(3):775-82. PubMed ID: 21360507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database.
    Walker UA; Tyndall A; Czirják L; Denton C; Farge-Bancel D; Kowal-Bielecka O; Müller-Ladner U; Bocelli-Tyndall C; Matucci-Cerinic M
    Ann Rheum Dis; 2007 Jun; 66(6):754-63. PubMed ID: 17234652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma beta-thromboglobulin in the differential diagnosis of Raynaud's phenomenon.
    Seibold JR; Harris JN
    J Rheumatol; 1985 Feb; 12(1):99-103. PubMed ID: 2580093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Raynaud's phenomena: diagnostic and treatment study].
    Priollet P
    Rev Prat; 1998 Oct; 48(15):1659-64. PubMed ID: 9814067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Responses to nifedipine by patients with Raynaud's disease and Raynaud's phenomenon secondary to another disease.
    Riccio A; Del Puente A; Farinaro C; Scarpa R; Oriente P; Rocco P; Gioia M
    Clin Ther; 1987; 9(2):232-7. PubMed ID: 3568066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Raynaud's phenomenon and systemic sclerosis.
    Generini S; Kahaleh B; Matucci-Cerinic M; Pignone A; Lombardi A; Ohtsuka T
    Ann Ital Med Int; 1996; 11(2):125-31. PubMed ID: 8974438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do the telangiectases of hereditary hemorrhagic telangiectasia and the calcinosis, Raynaud's disease, sclerodactyly, telangiectasia variant of scleroderma have a common etiology?
    Braverman IM
    Dermatology; 2006; 213(2):81-2. PubMed ID: 16902282
    [No Abstract]   [Full Text] [Related]  

  • 16. [Capillaroscopic evaluation of the effects of nifedipine in patients with Raynaud's phenomenon].
    Riccio A; Pennarola R; Farinaro C; Scherillo G; Infranzi E; Del Puente A; Oriente P
    Clin Ter; 1988 May; 125(3):185-90. PubMed ID: 2973939
    [No Abstract]   [Full Text] [Related]  

  • 17. Increased plasma adrenomedullin concentrations in patients with Raynaud's phenomenon.
    Letizia C; Danese C; D'Erasmo E
    J Rheumatol; 1999 Mar; 26(3):759-60. PubMed ID: 10090204
    [No Abstract]   [Full Text] [Related]  

  • 18. Image analysis of nail fold capillaries in patients with Raynaud's phenomenon.
    Ohtsuka T; Yamakage A; Tamura T
    Cutis; 1995 Oct; 56(4):215-8. PubMed ID: 8575220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of clonazepam on Raynaud's phenomenon and fingertip ulcers in scleroderma.
    Colakoğlu M; Cobankara V; Akpolat T
    Ann Pharmacother; 2007 Sep; 41(9):1544-7. PubMed ID: 17666574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Contemporaneous clinical picture of systemic sclerosis].
    Wiesik-Szewczyk E; Olesińska M
    Pol Merkur Lekarski; 2010 May; 28(167):416-20. PubMed ID: 20568410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.